Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1996-3-25
pubmed:abstractText
We have established three kinds of monoclonal antibodies against gangliosides containing N-glycolylneuraminic acid (NeuGc) by immunization of BALB/c mice with the purified gangliosides inserted into liposomes comprising Salmonella minnesota R595 lipopolysaccharides, and fusion of spleen cells with a mouse myeloma cell line. One monoclonal antibody, SHS-1, which was generated by immunizing mice with purified i-active ganglioside(NeuGc), reacted specifically with the i-active ganglioside(NeuGc) used as an immunogen. Structurally related gangliosides, such as GM3(NeuGc), sialosylparagloboside (SPG) (NeuGc), or I-active ganglioside(NeuGc), corresponding gangliosides [GM3 containing N-acetylneuraminic acid (NeuAc), SPG(NeuAc), i-active ganglioside(NeuAc), and I-active ganglioside(NeuAc)], other gangliosides, or neutral glycosphingolipid (GSL) were not recognized by the monoclonal antibody. These findings indicate that the SHS-1 monoclonal antibody may be specific for NeuGc-containing i-active ganglioside. On the other hand, the other two monoclonal antibodies, MSG-1 and SPS-20, which were generated by immunizing mice with purified ganglioside GM3(NeuGc) and SPG(NeuGc), respectively, showed cross-reactivity to structurally related gangliosides. The MSG-1 monoclonal antibody exhibited reactivity to ganglioside GM3(NeuAc). The SPS-20 monoclonal antibody also cross-reacted with SPG(NeuAc), i-active ganglioside(NeuGc), and i-active ganglioside(NeuAc). Neither MSG-1 nor SPS-20 reacted with corresponding gangliosides, other gangliosides, or neutral GSLs tested. Using the SHS-1 antibody specific for i-active ganglioside(NeuGc), we studied the expression of NeuGc-containing antigen in human colon cancer tissue. An NeuGc-containing glycoconjugate was detected in the colon cancer tissue.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0021-924X
pubmed:author
pubmed:issnType
Print
pubmed:volume
117
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1062-9
pubmed:dateRevised
2007-12-19
pubmed:meshHeading
pubmed-meshheading:8586620-Animals, pubmed-meshheading:8586620-Antibodies, Heterophile, pubmed-meshheading:8586620-Antibodies, Monoclonal, pubmed-meshheading:8586620-Antibody Formation, pubmed-meshheading:8586620-Antibody Specificity, pubmed-meshheading:8586620-Antigens, Heterophile, pubmed-meshheading:8586620-Antigens, Neoplasm, pubmed-meshheading:8586620-Carbohydrate Sequence, pubmed-meshheading:8586620-Colonic Neoplasms, pubmed-meshheading:8586620-Gangliosides, pubmed-meshheading:8586620-Globosides, pubmed-meshheading:8586620-Humans, pubmed-meshheading:8586620-Immunohistochemistry, pubmed-meshheading:8586620-Liposomes, pubmed-meshheading:8586620-Mice, pubmed-meshheading:8586620-Mice, Inbred BALB C, pubmed-meshheading:8586620-Molecular Sequence Data, pubmed-meshheading:8586620-Neuraminic Acids
pubmed:year
1995
pubmed:articleTitle
Production of monoclonal antibodies directed to Hanganutziu-Deicher active gangliosides, N-glycolylneuraminic acid-containing gangliosides.
pubmed:affiliation
Department of Cell Chemistry, Okayama University Medical School.
pubmed:publicationType
Journal Article